Hospital in the home (HITH) care following autologous stem cell transplantation for lymphoma and multiple myeloma
| Autor: | Wendy, Johnson, Ian, Kerridge, Cathie, Milton, Debbie, Carr, Arno, Enno, Louisa, Bray, Angela, Booth |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Adult
Male Antimetabolites Antineoplastic Transplantation Conditioning Lymphoma Home Care Services Hospital-Based Patient Readmission Transplantation Autologous Clinical Protocols Lomustine Antineoplastic Combined Chemotherapy Protocols Humans Antineoplastic Agents Alkylating Cyclophosphamide Melphalan Aged Etoposide Nursing Audit Cytarabine Middle Aged Antineoplastic Agents Phytogenic Outcome and Process Assessment Health Care Female New South Wales Multiple Myeloma Stem Cell Transplantation |
| Zdroj: | The Australian journal of advanced nursing : a quarterly publication of the Royal Australian Nursing Federation. 23(4) |
| ISSN: | 0813-0531 |
| Popis: | Advances in outpatient and supportive care and increased pressure on hospital bed usage has led to the investigation of hospital in the home (HITH) management following autologous haematologous stem cell transplantation (AutoHSCT) for patients with multiple myeloma or lymphoma.The Newcastle Mater Hospital Haematology Unit together with the Mater Acute Care Community Service (MACCS) developed a protocol for HITH care following AutoHSCT.Clinical outcomes of the protocol were audited: 40% (13) of patients were suitable candidates for HITH care post transplantation. Of these 84.6% (11) were readmitted to the haematology unit within seven days of discharge from hospital.Our preliminary experience suggests that with adequate infrastructure support and rigorous patient selection this model of care is both safe and feasible. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|